Stage
No active trials
Next date
None yet
Trials
0 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Diabetic Foot Ulcers (2 trials), Ulcers
- Main trialPhase 2
- “This is a Phase II, randomized, controlled, two-center pilot study designed to assess the safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects meeting entry criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either MEBO or SOC (7 subjects per treatment arm).”In the company’s words, NCT01138436 on ClinicalTrials.gov
- Other names
- MEBO
Other drugs for Diabetic Foot Ulcers
- BIOxHEALApplied Biologics, LLC · Phase 3
- Amniotic Tissue AllograftBardia Anvar · Phase 3
- ENERGI-F703Energenesis Biomedical Co., Ltd. · Phase 3
- Xianglei Tangzu GaoOneness Biotech Co., Ltd. · Phase 2/3
- Nu-3 gelLakewood-Amedex Inc · Phase 2
- Antimicrobial Peptide PL-5 Topical SprayJiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. · Phase 2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Completed | Oct 2011 | A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers | |
| Phase 2Completed | Oct 2011 | A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot) | |
| Phase 2Completed | Sep 2013 | A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026